Add Yahoo as a preferred source to see more of our stories on Google. The genetic disorder cystic fibrosis is unique because it can cause both breathing and digestive problems. Some 40,000 people in ...

Alyftrek (vanzacaftor/tezacaftor/deutivacaftor) is a combination medicine approved by the FDA in 2024. Alyftrek is approved to treat people ages 6 and older who have ...

Cystic fibrosis is among the most common, known and studied genetic diseases. It affects over 100,000 people worldwide and ...

As a 40-year-old who lives with cystic fibrosis (CF), Zachary Schulz, PhD, EdS, MPH, is said to be among the reputed “last generation” of patients — those born before the advent of drugs that target ...

Despite new medication, cystic fibrosis often leads to permanent lung damage. Researchers have discovered that the disease causes changes in the immune system early in life, presumably even in ...

A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...

The desire to have children represents one of the most fundamental human experiences, yet for people living with cystic fibrosis, the path to parenthood can feel uncertain and complex. You might ...

Breathing disorders are common in the U.S. with conditions like COPD affecting some 7% of the population and asthma affecting another 10%. Digestive conditions like GERD, acid reflux, Celiac disease ...